Therachon
develops protein therapeutics for the treatment of achondroplasia... Read moreTherachon
develops protein therapeutics for the treatment of achondroplasia... Read more
News
Jan 08, 2020
startupticker ch
Therachon: Therachon spin-off launches with $35 million investment
Jul 02, 2019
PharmaTech
Therachon: Pfizer Completes Acquisition of Clinical-Stage Biotech
May 22, 2019
Pharamceutical Technology
Therachon: Pfizer acquires Therachon to broaden its rare disease pipeline
May 17, 2019
FinanzNachrichten
Therachon: Therachon to Present Data from Ongoing Phase II Study of Apraglutide for Short Bowel Syndrome (SBS) at Digestive Disease Week
May 13, 2019
BioPharm
Therachon: Pfizer to Acquire Biotech Firm Therachon in Deal Worth $810 Million
May 08, 2019
BioCentury
Therachon: With Therachon takeout, Pfizer obtains achondroplasia program
May 08, 2019
FinSMEs
Therachon: Pfizer Acquires Clinical-Stage Biotech Company Therachon, for Up To $810M
May 08, 2019
BioCentury
Therachon: Why Dwarfism start-up Therachon picked Pfizer takeout over IPO
Mar 25, 2019
FinanzNachrichten
Therachon: Therachon Presents Data from Preclinical and Phase I clinical Studies of Apraglutide for the Treatment of Short Bowel Syndrome at ASPEN 2019 Nutrition Science & Practice Conference
Jan 21, 2019
startupticker
Therachon: Biotech startups strengthen their teams for the next steps
Therachon Competitors
1
2
3
4
5
6
7
8
9
10